Morocco latest patents query
The latest invention patents collect the data information of Morocco invention patents from 2000 to 2024, typesetting according to the date of patent publication, including patent number, application date, invention Bibliographic data, abstracts, and specification data of people are convenient for scientific researchers to quickly browse and search for patents.
METHOD FOR REMOVING INSULATION FROM INTERNAL CONDUCTORS IN A CABLE AND STRIPPING DEVICE
UndeterminedMA53254A
Owner:KOMAX HOLDING
CANCER TREATMENT WITH HER2XCD3 BISPECIFIC ANTIBODIES IN COMBINATION WITH AN ANTI-HER2 MAB
UndeterminedMA55296A
Owner:F HOFFMANN LA ROCHE & CO AG
Anti-CLDN chimeric antigenic receptors and methods of use
UndeterminedMA40921A
Owner:ABBVIE STEMCENTRX LLC
Phosphoramidate diphosphate nucleoside salts used as anticancer compounds
UndeterminedMA51006A
Owner:NUCANA PLC
SAFETY SUBSTRATES, SAFETY DEVICES AND THEIR MANUFACTURING PROCESSES
UndeterminedMA42901A
Owner:DE LA RUE INTERNATIONAL LTD
COMPOSITIONS AND METHODS FOR INHIBITING ARGINASE ACTIVITY
UndeterminedMA42269A
Owner:CALITHERA BIOSCIENCES INC
METALLIC SHOCK ABSORPTION ELEMENT FOR MOTOR VEHICLES AND ASSOCIATED PRODUCTION METHOD
UndeterminedMA49958A
Owner:SRT
STATIN-BASED COMPOSITIONS AND METHODS INTENDED FOR USE IN THE TREATMENT OF SYNUCLEINOPATHIES
UndeterminedMA52691A
Owner:CHASE THERAPEUTICS CORP
METHOD AND DEVICE FOR REDUCING NOX EMISSIONS FROM A ROTARY TUBULAR FURNACE
ActiveMA42787A
Owner:HOLCIM TECHNOLOGY LTD
SYSTEM AND METHOD FOR TESTING THE PERFORMANCE OF A COMPUTER INFRASTRUCTURE
UndeterminedMA39623A
Owner:BULL SA
Lactone-containing compositions for malodor elimination
UndeterminedMA40387A
Owner:TAKASAGO INTERNATIONAL CORP
PROCESSES FOR PRODUCING TUMOR-INFILTRATING LYMPHOCYTES AND THEIR USES IN IMMUNOTHERAPY
Owner:IOVANCE BIOTHERAPEUTICS INC
ANTIBODY COMPOSITIONS FOR THE TREATMENT OF TUMORS
Owner:REGENERON PHARMACEUTICALS INC
TOPICAL PHARMACEUTICAL COMPOSITIONS
Owner:DERMAVANT SCI GMBH
PYRAZOLO[3,4-B]PYRIDINE COMPOUNDS USED AS TAM AND MET KINASE INHIBITORS
UndeterminedMA53487A
Owner:ARRAY BIOPHARMA INC
METHOD AND DEVICE FOR ACTIVATION CONTROL FOR TRAIN
UndeterminedMA51163A
Owner:CRRC QINGDAO SIFANG CO LTD
[1,2,3]TRIAZOLO[4,5-D]PYRIMIDINE DERIVATIVES WITH AN AFFINITY FOR THE TYPE 2 CANNABINOID RECEPTOR
UndeterminedMA45442A
Owner:F HOFFMANN LA ROCHE & CO AG
Peptides intended for use in immunotherapy against cancer
UndeterminedMA52614A
Owner:IMMATICS BIOTECHNOLOGIES GMBH
DEVICE AND METHOD FOR DISTRIBUTING DISINFECTION AND / OR CLEANING AGENTS
UndeterminedMA45501A
Owner:WILHELM SCHUETZ KG
MACHINE FOR BLOW MOLD OR STRETCH-BLUE MOLD OF BOTTLES IN A POLYMER MATERIAL
UndeterminedMA39005A
Owner:SMI SPA
PREPARATION OF SOLID CYCLODEXTRIN COMPLEXES ALLOWING ADMINISTRATION OF OPHTHALMIC ACTIVE PHARMACEUTICAL SUBSTANCE
Owner:OCULIS SA
GENETICALLY MODIFIED STERILE BIRDS AND THE PROCESS FOR THEIR RECONSTITUTION
UndeterminedMA53853A
Owner:THE UNIV COURT OF THE UNIV OF EDINBURGH
COMPOSITIONS AND METHODS FOR CONTROLLING STRONG ACID SYSTEMS
UndeterminedMA49462A
Owner:SAUDI ARABIAN OIL CO
PISUM SATIVUM KAURENE OXIDASE FOR HIGH-YIELD REBAUDIOSIDES PRODUCTION
UndeterminedMA49836A
Owner:AMYRIS INC
MG53 MUTANT, ITS PREPARATION PROCESS AND USES
UndeterminedMA45797A
Owner:HOPE MEDICINE (NANJING) CO LTD
IDENTIFICATION AND VISUALIZATION OF CARDIAC ACTIVATION SEQUENCES IN MULTICHANNEL RECORDINGS
UndeterminedMA42851A
Owner:BIOSENSE WEBSTER (ISRAEL) LTD
Bispecific anti-BCMA-X anti-CD3 antibodies and their uses
ActiveMA53168A
Owner:REGENERON PHARMACEUTICALS INC
IDENTIFICATION AND ISOLATION OF HUMAN OTIC PROGENITOR
Owner:UNIV OF SHEFFIELD
T-LYMPHOCYTE RECEPTORS AND IMMUNE THERAPY USING THEM
Owner:IMMATICS BIOTECHNOLOGIES GMBH
DIFFERENTIALLY EXPRESSED IMMUNE CELL MICRORNAS FOR PROTEIN EXPRESSION REGULATION
UndeterminedMA55887A
Owner:MODERNATX INC
NEW POLYMORPHIC FORM OF N-[2-(6-FLUORO-LH-INDOL-3-YL)ETHYL]-3-(2,2,3,3-TETRAFLUOROPROPOXY) BENZYLAMINE HYDROCHLORIDE FOR THE TREATMENT OF ALZHEIMER'S DISEASE
ActiveMA40345A
Owner:H LUNDBECK AS
INFRASTRUCTURE LINES AND ASSOCIATED CONTROL AND / OR COMMUNICATION NETWORKS
UndeterminedMA56454A
Owner:NETAFIM LTD
METHOD FOR TRAINING AT LEAST ONE ALGORITHM FOR A CONTROL DEVICE OF A MOTOR VEHICLE, COMPUTER PROGRAM PRODUCT, MOTOR VEHICLE AND SYSTEM
UndeterminedMA55962A
Owner:PSA AUTOMOBILES SA
METHYLATION CLASSIFIER FOR THE DETECTION OF HPV-INDUCED INVASIVE CANCERS, NON-HPV-INDUCED GYNECOLOGICAL AND ANOGENITAL CANCERS, AND THEIR HIGH-GRADE PRECURSOR LESIONS
UndeterminedMA47821A
Owner:SELF SCREEN
METHODS AND MATERIALS FOR NT-3 GENE THERAPY
UndeterminedMA50412A
Owner:RES INST AT NATIONWIDE CHILDRENS HOSPITAL
THERAPEUTIC COMBINATIONS, LIQUID PHARMACEUTICAL COMPOSITIONS, KITS FOR THEIR PREPARATION AND METHODS OF USE
UndeterminedMA55726A
Owner:PREVEP LLC
5-AMINO-6H-THIAZOLO[4,5-D]PYRIMIDINE-2,7-DIONE SUBSTITUTE COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF VIRAL INFECTIONS
ActiveMA41134A
Owner:F HOFFMANN LA ROCHE & CO AG
Compositions and methods for treating skin conditions using infrared light and resorcinols
UndeterminedMA53752A
Owner:JOHNSON & JOHNSON CONSUMER INC
Light-emitting laminated glazing for a vehicle, comprising inorganic light-emitting diodes, and production thereof
UndeterminedMA49354A
Owner:SAINT GOBAIN VITRAGE SA
METHOD FOR PRODUCING A HIGH-STRENGTH COATED STEEL SHEET WITH IMPROVED STRENGTH, DUCTILITY, AND FORMABILITY
UndeterminedMA53357A
Owner:ARCELORMITTAL SA
WIND TURBINE BLADE
InactiveMA40346Areduce trailing edge vorticesminimizing and lateral flow
Owner:LM WP PATENT HLDG AS
FULVESTRANT FORMULATIONS AND METHODS OF USE THESE
UndeterminedMA44862A
Owner:EAGLE PHARMACEUTICALS INC
MODIFIED B CELLS AND ASSOCIATED COMPOSITIONS AND METHODS
UndeterminedMA46959A
Owner:JUNO THERAPEUTICS INC
BICYCLIC ARYLMONOBACTAM COMPOUNDS AND THEIR METHODS OF USE FOR THE TREATMENT OF BACTERIAL INFECTIONS
UndeterminedMA43811A
Owner:MERCK SHARP & DOHME CORP
Pharmaceutical matrix formulations containing dimethyl fumarate
UndeterminedMA40990A
Owner:BIOGEN MA INC
METHOD FOR PREPARING A DRY POWDER FORMULATION CONTAINING AN ANTICHOLINERGIC, A CORTICOSTEROID AND A BETA-ADRENERGIC AGENT
UndeterminedMA48620A
Owner:CHIESI FARMACEUTICI SPA
FUEL COMPOUNDS BASED ON LIGHT SEALABLE OILS AND HIGH-SULFUR FUEL OILS
UndeterminedMA54788A
Owner:MAWETAL LLC
HEXAHYDRO-1H-PYRAZINO[1,2-A]PYRAZINE COMPOUNDS FOR THE TREATMENT OF AN AUTOIMMUNE DISEASE
UndeterminedMA55594A
Owner:F HOFFMANN LA ROCHE & CO AG
2-ARYL-4-HYDROXY-1,3-THIAZOLE DERIVATIVES AS TRPM8 ANTAGONISTS, AND THEIR USE IN THE TREATMENT OF NEURALGIA, PAIN, COPD AND ASTHMA.
Owner:DOMPE FARMACEUTICI SPA
CONJUGATED TUBULYSIN ANALOGUE WITH BRANCHED LINKERS
UndeterminedMA48610A
Owner:HANGZHOU DAC BIOTECH CO LTD
EFFECTIVE PROCESS FOR PREPARING CELL-BINDING AGENT-CYTOTOXIC AGENT CONJUGATES
UndeterminedMA47022A
Owner:IMMUNOGEN INC
METHOD FOR PRODUCING A HIGH-STRENGTH STEEL SHEET WITH IMPROVED DUCTILITY AND FORMABILITY, AND THE STEEL SHEET THUS OBTAINED
Owner:ARCELORMITTAL SA
HLA CLASS II RESTRICTED T-LYMPHOCYTE RECEPTORS VERSUS MUTANT KRAS
UndeterminedMA50180A
Owner:THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES
Oral-disposable palatable formulations of drotaverine and their preparation process
UndeterminedMA71629A
Owner:DROTASTAR LLC
PEPTIDES AND PEPTIDE COMBINATIONS INTENDED FOR USE IN CANCER IMMUNOTHERAPY
UndeterminedMA51170A
Owner:IMMATICS BIOTECHNOLOGIES GMBH
Slip-cut operation with static electric holding force and ultrasonic bonding apparatus
UndeterminedMA40593A
Owner:ANDREWS ROBERT E +5
METHOD FOR MANUFACTURED WOOD SHEETS FOR LAMPS AND WOOD SHEET OBTAINED
UndeterminedMA49523A
Owner:LUZIFERLAMPS
LOW-DOSE ISOTRETINOIN PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION
UndeterminedMA40781A
Owner:SUN PHARMACEUTICAL INDUSTRIES LTD
HETEROARYL SUBSTITUTED SULFONAMIDE COMPOUNDS AND THEIR USE AS SODIUM CHANNEL INHIBITORS
UndeterminedMA53488A
Owner:XENON PHARMACEUTICALS INC
MUSCARINIC RECEPTOR AGONIST POLYMORPHS
ActiveMA46464Amodify release characteristicfew steps
Owner:NSC THERAPEUTICS GMBH
METHOD FOR DETERMINING TUNA BIOMASS IN A WATER AREA AND CORRESPONDING SYSTEM
UndeterminedMA51648A
Owner:BALFEGO & BALFEGO SL +2
CANCER THERAPY USING A DISUBSTITUTED BENZENE-ALKYNYL 3,5-COMPONED COMPOUND AND PEMBROLIZUMAB
UndeterminedMA55091A
Owner:TAIHO PHARMA CO LTD
4,6-DIAMINO-PYRIDO[3,2-D]PYRIMIDINE COMPOUNDS TOLL-TYPE RECEPTOR MODULATORS
UndeterminedMA39601A
Owner:GILEAD SCIENCES INC
METHOD FOR PRINTING A STRUCTURED SILVER COATING WITH AN IMPROVED MAXIMUM ALLOWABLE CURRENT INTENSITY
UndeterminedMA52345A
Owner:SAINT GOBAIN VITRAGE SA
FIVE-LAYER MICROFLUIDIC BLOOD COAGULATION MEASUREMENT CHIP
UndeterminedMA56460A
Owner:NANJING LANSION BIOTECH CO LTD
METHOD FOR MANUFACTURED A SET OF BODYWORK PARTS BY CUTTING
UndeterminedMA41153A
Owner:COMPAGNIE PLASTIC OMNIUM SA
METHODS FOR PREPARING MODULATORS OF THE TRANSMEMBRANE CONDUCTANCE REGULATOR IN CYSTIC FIBROSIS
UndeterminedMA51039A
Owner:VERTEX PHARMACEUTICALS INC
POLYMER COMPOSITION BASED ON A THERMOPLASTIC COPOLYESTER ELASTOMER, MANUFACTURED ARTICLE MADE USING SAID POLYMER COMPOSITION, AND PRODUCTION METHOD FOR SAID POLYMER COMPOSITION
UndeterminedMA42784A
Owner:SO F TER
TYPE I AND TYPE II RECEPTOR HETEROMULTIMERS OF THE TGF-BETA SUPERFAMILY AND THEIR USES
UndeterminedMA54328A
Owner:ACCELERON PHARMA INC
SEAT MOUNTING STRUCTURE AND TRAIN EQUIPPED WITH THE LATTER
UndeterminedMA54621A
Owner:CRRC QINGDAO SIFANG CO LTD
SONOTRODE, DEVICE AND METHOD FOR ESTABLISHING A CONNECTION
UndeterminedMA42511A
Owner:TELSONIC HLDG AG
ANTIBODIES NEUTRALIZING THE HUMAN RESPIRATORY SYNCYTIAL VIRUS
Owner:MERCK SHARP & DOHME LLC
METHODS FOR TREATING DEPRESSION USING OREXIN-2 RECEPTOR ANTAGONISTS
ActiveMA43817A
Owner:JANSSEN PHARMA NV
PROCESS FOR THE DESTRUCTION AND RECYCLING OF ASBESTOS WASTE
UndeterminedMA51702A
Owner:CENT NAT DE LA RECH SCI (C N R S) +2
LABEL, SYSTEM AND METHOD FOR LONG-DISTANCE OBJECT DETECTION
UndeterminedMA44675A
Owner:UNIV COMPLUTENSE DE MADRID
A PROCESS FOR TREATMENT OF HALOGENATED SALTS COMPRISING TWO IDENTICAL ELECTRODES
UndeterminedMA55358A
Owner:DEUTSCHES ZENTRUM FÜR LUFT UND RAUMFAHRT E V
AGENTS, USES AND METHODS FOR THE TREATMENT OF SYNUCLEINOPATHY
Owner:H LUNDBECK AS
AIR-FILLED DEVICE SUCH AS A RELIEF DEVICE EQUIPPED WITH A QUICK-CLOSING MEANS
UndeterminedMA55722A
Owner:CHARPIOT GEOFFREY
Modulators of toll-like receptors for the treatment of HIV
UndeterminedMA40238A
Owner:GILEAD SCIENCES INC
CARPET TILE, IN PARTICULAR CARPET TILE, AND FLOORING MADE OF SUCH TILE
UndeterminedMA51557A
Owner:I4F LICENSING NV
BIOLOGICAL COMPOSITION FOR THE PREVENTION OF NITRATE LEACHING
UndeterminedMA71339A
Owner:FERTIBERIA S A
AMINOPYRIMIDINE AMIDE-BASED AUTOPHAGIA INHIBITORS AND THEIR METHODS OF USE
UndeterminedMA56191A
Owner:DECIPHERA PHARMACEUTICALS LLC
METHOD FOR MANAGING ENGINE TORQUE DURING A FUEL INJECTION RECOVERY PHASE
UndeterminedMA47725A
Owner:PSA AUTOMOBILES SA
MOTOR VEHICLE CROSSING SYSTEM RECEPTING A TRANSVERSE GUIDE BAR
UndeterminedMA50152A
Owner:PSA AUTOMOBILES SA
SIGNALING DEVICE WITH INTEGRATED ACCELEROMETER WORN ON THE BACK OF A MOTOR VEHICLE OPERATOR
InactiveMA51125A
Owner:AIT EL HADJ MOHAMED
COMPOSITION AND PROCESSES OF REGULATION OF INHIBITORY INTERACTIONS IN GENETICALLY MODIFIED CELLS
UndeterminedMA43344A
Owner:JUNO THERAPEUTICS INC
STABLE ORAL LIQUID PHARMACEUTICAL FORMULATION OF AN ANTISPASMODIC AGENT
UndeterminedMA71627A
Owner:DROTASTAR LLC
NEW PEPTIDES AND PEPTIDE COMBINATIONS INTENDED FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS (SEQ ID 23 - MMP-002)
UndeterminedMA43438A
Owner:IMMATICS BIOTECHNOLOGIES GMBH
METHOD, WORK LIGHTING AND WORK MACHINE INTENDED FOR ADJUSTING LIGHTING MEANS
UndeterminedMA46593A
Owner:HELLA GMBH & CO KGAA